Long-term in vitro and in vivo effects of γ-irradiated BCG on innate and adaptive immunity (Q40828543)

24 September 2017

Long-term in vitro and in vivo effects of γ-irradiated BCG on innate and adaptive immunity (English)

1 reference

24 September 2017

8

Reinout van Crevel

0 references

Peter Aaby

object named as

Peter Aaby

3

0 references

Christine Stabell Benn

7

object named as

Christine Stabell Benn

1 reference

24 September 2017

9

Mihai G Netea

1 reference

24 September 2017

4

Leo A B Joosten

1 reference

24 September 2017

Jos W. M. van der Meer,

6

object named as

Jos W M van der Meer

1 reference

24 September 2017

Rob J W Arts

1

1 reference

24 September 2017

Bastiaan A Blok

2

1 reference

24 September 2017

Dirk de Jong

5

1 reference

24 September 2017

16 June 2015

1 reference

Journal of Leukocyte Biology

24 September 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

24 September 2017

98

1 reference

24 September 2017

6

1 reference

24 September 2017

995-1001

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4MA0215-059R

24 September 2017

1 reference

Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4MA0215-059R

Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period?

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4MA0215-059R

Small randomized trial among low-birth-weight children receiving bacillus Calmette-Guérin vaccination at first health center contact

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4MA0215-059R

Low birth weight infants and Calmette-Guérin bacillus vaccination at birth: community study from Guinea-Bissau

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4MA0215-059R

Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4MA0215-059R

Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4MA0215-059R

A small jab - a big effect: nonspecific immunomodulation by vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4MA0215-059R

Trained immunity: a memory for innate host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4MA0215-059R

Prevention of tuberculosis in Bacille Calmette-Guérin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4MA0215-059R

Mycobacterium tuberculosis Hip1 dampens macrophage proinflammatory responses by limiting toll-like receptor 2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4MA0215-059R

Enhancement of Mycobacterium tuberculosis-induced tumor necrosis factor alpha production from primary human monocytes by an activated T-cell membrane-mediated mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4MA0215-059R

Bartonella quintana lipopolysaccharide is a natural antagonist of Toll-like receptor 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4MA0215-059R

BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa. A non-specific beneficial effect of BCG?

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4MA0215-059R

BCG vaccination scar associated with better childhood survival in Guinea-Bissau

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4MA0215-059R

Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: a beneficial effect of BCG vaccination for girls community based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4MA0215-059R

Nonspecific effects of vaccines and the reduction of mortality in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4MA0215-059R

A human challenge model for Mycobacterium tuberculosis using Mycobacterium bovis bacille Calmette-Guerin

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4MA0215-059R

Heterologous immunity: immunopathology, autoimmunity and protection during viral infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4MA0215-059R

Loss of anti-viral immunity by infection with a virus encoding a cross-reactive pathogenic epitope.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4MA0215-059R

CD4 T-cell-mediated heterologous immunity between mycobacteria and poxviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4MA0215-059R

Bystander activation of CD8+ T cells contributes to the rapid production of IFN-gamma in response to bacterial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4MA0215-059R

Contribution of CD8+ T cells to innate immunity: IFN-gamma secretion induced by IL-12 and IL-18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4MA0215-059R

Memory CD8+ T cells provide innate immune protection against Listeria monocytogenes in the absence of cognate antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4MA0215-059R

Tyk2-dependent bystander activation of conventional and nonconventional Th1 cell subsets contributes to innate host defense against Listeria monocytogenes infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4MA0215-059R

Naive and innate memory phenotype CD4+ T cells have different requirements for active Itk for their development

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4MA0215-059R

Immunodominant PstS1 antigen of mycobacterium tuberculosis is a potent biological response modifier for the treatment of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4MA0215-059R

Mycobacterium tuberculosis PstS1 amplifies IFN-γ and induces IL-17/IL-22 responses by unrelated memory CD4+ T cells via dendritic cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4MA0215-059R

21 January 2018

Identifiers

DOI

10.1189/JLB.4MA0215-059R

1 reference

24 September 2017

1 reference